Electromedical Technologies Adds Former
Aerospace CEO and Current Management Expert Lee Benson to Board of
Directors
Scottsdale, Arizona -- June 14, 2022 -- InvestorsHub
NewsWire -- Electromedical Technologies, Inc. (OTCQB:
EMED) ("Electromedical" or the "Company"), a pioneer in the
development and production of advanced bioelectronic devices that
offer a drug free way to relieve chronic, intractable, and acute
pain by using frequencies and electro-modulation, is excited to
announce the addition of Lee Benson, CEO of ETW (Execute to Win)
(etw.com),
to the Company's Board of Directors.
"Lee will add tremendous value to the Board and the
company, given his track record as a leader in a field
driven by engineering expertise, his business acumen, his
extraordinary deal-making experience, and his proven management
insights and proven strategies, we couldn't be more excited to
welcome him to the Electromedical team," remarked Matthew Wolfson,
founder and CEO of Electromedical. "We are on the precipice of
perhaps our most important period of scaling the business, and it
gives me great confidence to know that we will be able to tap Lee's
insights and guidance as a very accomplished businessman and high
level entrepreneur during this key period. A company can
only be as good as the people who are involved. Lee can help us
reach higher levels of growth, culture and execution."
Lee Benson started his career as the first employee in a small
company providing specialty electroplating services to repair
aircraft components. Benson purchased the company 1993 after a
sudden sharp decline in business. He then went on to turn things
completely around. He founded Able Engineering & Component
Services in 1995 and Able Aerospace in 1999, subsequently expanding
from 3 to 500+ employees and driving 15 straight years of 20
percent compounded average annual growth.
Benson sold Able Aerospace to global powerhouse Textron
Aviation in a Nine-figure deal. Textron (TNT Nasdaq) itself includes
the Beechcraft, Hawker,
Bell
and Cessna brands.
After he secured the deal, Lee founded ETW to help other
businesses achieve maximum success and profit from his experience
and expertise. To this day, Lee's unique management system forms
the foundation of ETW and was praised by legendary business leader,
former CEO of GE Jack Welch, as the best management
system Welch had ever seen. This management system is what
Electromedical has implemented and uses on a daily basis.
"Electromedical has a fantastic product and incredible
potential to scale. I look forward to working with Matthew and his
terrific team at Electromedical as the Company prepares to level up
its business growth in the months and quarters ahead, this is a
critical time for the Company – an exciting time. And I see
explosive potential waiting to be unlocked." stated
Benson.
About Electromedical Technologies
Headquartered in Scottsdale, Arizona, Electromedical Technologies,
Inc. is a commercial stage, FDA cleared, bioelectronic medical
device manufacturing company initially focused on the treatment of
various chronic, acute, intractable, and post-operative pain
conditions. Through University collaboration agreements, the
Company is working to develop a comprehensive research program in
defining the effects of electro-modulation on the human body. By
studying the impacts of electrical fields in cell signaling and
effects on virus assembly and immune responses, the Company's goal
is to reduce pain and improve overall human wellbeing. The
Company's current FDA cleared product indications are for chronic
acute post traumatic and post-operative, intractable pain
relief.
For more information, please visit www.electromedtech.com.
Note: Nonhuman preliminary studies that we are planning to start
in the near future and their applications are not related to our
current product in any way and are currently not cleared in the
US.
Safe Harbor Statement
This release contains forward-looking statements that are based
upon current expectations or beliefs, as well as a number of
assumptions about future events. Although we believe that the
expectations reflected in the forward-looking statements and the
assumptions upon which they are based are reasonable, we can give
no assurance or guarantee that such expectations and assumptions
will prove to have been correct. Forward-looking statements are
generally identifiable by the use of words like "may," "will,"
"should," "could," "expect," "anticipate," "estimate," "believe,"
"intend," or "project" or the negative of these words or other
variations on these words or comparable terminology. The reader is
cautioned not to put undue reliance on these forward-looking
statements, as these statements are subject to numerous factors and
uncertainties, including but not limited to: adverse economic
conditions, competition, adverse federal, state and local
government regulation, international governmental regulation,
inadequate capital, inability to carry out research, development
and commercialization plans, loss or retirement of key executives
and other specific risks. To the extent that statements in this
press release are not strictly historical, including statements as
to revenue projections, business strategy, outlook, objectives,
future milestones, plans, intentions, goals, future financial
conditions, events conditioned on stockholder or other approval, or
otherwise as to future events, such statements are forward-looking,
and are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. The forward-looking
statements contained in this release are subject to certain risks
and uncertainties that could cause actual results to differ
materially from the statements made.
Corporate Contact:
Electromedical Technologies, Inc.
Tel: 1.888.880.7888
Email: ir@electromedtech.com
https://electromedtech.com
Public Relations:
EDM Media,
LLC
https://edm.media